The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1

Cited by papers we hold 13

• Mitochondrial quality control in human health and disease · 2024
  No notice
• Oxidative stress as a key modulator of cell fate decision in osteoarthritis and osteoporosis: a narrative review · 2023
  No notice
• Molecular Mechanisms of Mitochondrial Quality Control in Ischemic Cardiomyopathy · 2023
  No notice
• Oxidative Stress and Mitochondrial Dysfunction in Chronic Kidney Disease · 2022
  No notice
• Signaling pathways of chronic kidney diseases, implications for therapeutics · 2022
  No notice
• AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice · 2021
  No notice
• The Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases · 2020
  No notice
• HIF‐1α ameliorates tubular injury in diabetic nephropathy via HO‐1–mediated control of mitochondrial dynamics · 2020
  No notice
• The mitochondria‐targeted anti‐oxidant MitoQ protects against intervertebral disc degeneration by ameliorating mitochondrial dysfunction and redox imbalance · 2020
  No notice
• Regulation of Nrf2 by Mitochondrial Reactive Oxygen Species in Physiology and Pathology · 2020
  No notice
• Wnt/β‐catenin/RAS signaling mediates age‐related renal fibrosis and is associated with mitochondrial dysfunction · 2019
  Corrected
• The mitochondrially targeted antioxidant MitoQ protects the intestinal barrier by ameliorating mitochondrial DNA damage via the Nrf2/ARE signaling pathway · 2018
  No notice
• Defective Autophagy in Atherosclerosis: To Die or to Senesce? · 2018
  No notice

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.